Newswise — People with type 2 diabetes are at greater risk of serious liver disease than those without the condition, new research has shown.

Researchers warn that hospital admissions and deaths caused by liver disease are likely to rise if cases of type 2 diabetes continue to increase at current rates.

The team, involving researchers from the Universities of Southampton and Edinburgh, examined cases of liver diseases among people with diabetes from anonymised, securely linked hospital records and death records in Scotland over a 10 year period.

They found that most cases of liver disease in people with type 2 diabetes are not alcohol-related but caused by a build-up of fat within liver cells – a condition known as non-alcoholic fatty liver disease (NAFLD).

NAFLD is commonly linked to obesity, which is also a risk factor for type 2 diabetes.

Most people can avoid getting these conditions by following a healthy diet and taking regular exercise.

The research team found that men with type 2 diabetes are three times more likely to suffer from NAFLD than men without diabetes.

There are fewer cases of type 2 diabetes and liver disease amongst women but having type 2 diabetes increases the risk of NAFLD by five times, the study found.

People with NAFLD are more susceptible to the effects of alcohol on the liver and should avoid drinking to avoid further complications, the researchers say.

Treatment options for NAFLD – which increases the risk of life-threatening complications such as cirrhosis and liver cancer – are limited.

The study involved researchers from the Scottish and Southampton Diabetes and Liver Disease Group. It is published in the Journal of Hepatology and was funded by the Scottish Government through the Scottish Diabetes Group.

Professor Sarah Wild, of the University of Edinburgh’s Usher Institute for Population Health Sciences, said: “Preventing non-alcoholic fatty liver disease by avoiding unhealthy lifestyles in both people with and without diabetes is important because it is difficult to treat the complications of this condition.”

Professor Chris Byrne, of the University of Southampton and National Institute for Health Research Southampton Biomedical Research Centre, said: “We have shown for the first time that type 2 diabetes is an important novel risk factor that increases numbers of hospital admissions and deaths, in people with all common chronic liver diseases. Further research is now needed to determine whether all patients with type 2 diabetes should be screened for common chronic liver diseases.”

ENDS

Notes to editors

1. A copy of the paper entitled: Type 2 diabetes, chronic liver disease and hepatocellular cancer: a national retrospective cohort study using linked routine data, is available from Media Relations upon request. DOI: http://dx.doi.org/10.1016/j.jhep.2016.01.014

2. Through world-leading research and enterprise activities, the University of Southampton connects with businesses to create real-world solutions to global issues. Through its educational offering, it works with partners around the world to offer relevant, flexible education, which trains students for jobs not even thought of. This connectivity is what sets Southampton apart from the rest; we make connections and change the world. http://www.southampton.ac.uk/ http://www.southampton.ac.uk/weareconnected#weareconnected

3. The National Institute for Health Research (NIHR) is funded by the Department of Health to improve the health and wealth of the nation through research. The NIHR is the research arm of the NHS. Since its establishment in April 2006, the NIHR has transformed research in the NHS. It has increased the volume of applied health research for the benefit of patients and the public, driven faster translation of basic science discoveries into tangible benefits for patients and the economy, and developed and supported the people who conduct and contribute to applied health research. The NIHR plays a key role in the Government’s strategy for economic growth, attracting investment by the life-sciences industries through its world-class infrastructure for health research. Together, the NIHR people, programmes, centres of excellence and systems represent the most integrated health research system in the world. For further information, visit the NIHR website (www.nihr.ac.uk ). #NIHR

For more information:

Becky Attwood, Media Relations Officer, University of Southampton, Tel: 02380 592128, Mob: 07342060429, Email: [email protected]

Jen Middleton, Press and PR Office, University of Edinburgh, Tel: 0131 650 6514; email [email protected]

Journal Link: Journal of Hepatology